Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems-Reference-Cited by-同舟云学术

Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems

Published:2021-10-06 Issue:12 Volume:44 Page:1323-1339
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Blotière Pierre-Olivier^ORCID,Damase-Michel Christine^ORCID,Weill Alain^ORCID,Maura Géric^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-021-01117-4.pdf

Reference45 articles.

1. European Medicines Agency (EMA). Valproate and related substances: new measures to avoid valproate exposure in pregnancy endorsed. 2018. https://www.ema.europa.eu/en/medicines/human/referrals/valproate-related-substances-0. Accessed 23 Apr 2019.

2. Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20:895–902.

3. Blattner CM, Danesh M, Safaee M, Murase JE. Understanding the new FDA pregnancy and lactation labeling rules. Int J Womens Dermatol. 2016;2:5–7.

4. Australian Government, Department of Health. Therapeutic Goods Administration (TGA). Prescribing medicines in pregnancy database. 2019. https://www.tga.gov.au/prescribing-medicines-pregnancy-database. Accessed 3 Jan 2020.

5. Swedish Catalogue of Approved Drugs (FASS). https://www.fass.se/LIF/startpage. Accessed 3 Jan 2020.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surveillance des médicaments chez les femmes enceintes : à propos du réseau Regards;Sages-Femmes;2023-11

2. Prevalence and associated factors of antibiotic exposure during pregnancy in a large French population-based study during the 2010–19 period;Journal of Antimicrobial Chemotherapy;2023-08-25

3. Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain;BMJ Open;2023-08

4. Toxicité fœtale et néonatale des inhibiteurs de l’enzyme de conversion et des sartans : quelle surveillance pour les enfants exposés in utero ?;Gynécologie Obstétrique Fertilité & Sénologie ;2023-06

5. Fingolimod, teriflunomide and cladribine for the treatment of multiple sclerosis in women of childbearing age: description of drug utilization and exposed pregnancies in Germany;Multiple Sclerosis and Related Disorders;2022-11